Search Results - "SCHMADER, K"

Refine Results
  1. 1
  2. 2

    Herpes Zoster in Older Adults by Yoshikawa, Thomas T., Schmader, Kenneth

    Published in Clinical infectious diseases (15-05-2001)
    “…Herpes zoster (HZ) strikes millions of older adults annually worldwide and disables a substantial number of them via postherpetic neuralgia (PHN). Key…”
    Get full text
    Journal Article
  3. 3

    Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients by Lee, R.H., Curtis, J., Drake, M.T., Bobo Tanner, S., Lenert, L., Schmader, K., Pieper, C., North, R., Lyles, K.W.

    Published in Osteoporosis international (2024)
    “…Summary COVID-19 infection has resulted in significant morbidity and mortality globally, especially among older adults. Repurposed drugs have demonstrated…”
    Get full text
    Journal Article
  4. 4

    Functional Status After Lung Transplantation in Older Adults in the Post‐Allocation Score Era by Genao, L., Whitson, H. E., Zaas, D., Sanders, L. L., Schmader, K. E.

    Published in American journal of transplantation (01-01-2013)
    “…This manuscript describes the functional status trajectory of older (age 65 or older) and younger (age 18–64) adults after lung transplantation (LT). After the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine by Schmader, Kenneth, Gnann, John W., Watson, C. Peter

    Published in The Journal of infectious diseases (01-03-2008)
    “…Worldwide, herpes zoster (HZ) affects millions of patients (particularly older adults) annually and causes significant suffering due to acute and chronic pain,…”
    Get full text
    Journal Article
  7. 7

    Suboptimal Prescribing in Older Inpatients and Outpatients by Hanlon, Joseph T., Schmader, Kenneth E., Ruby, Christine M., Weinberger, Morris

    “…Investigators searched Medline and HealthSTAR databases from January 1, 1985 through June 30, 1999 to identify articles on suboptimal prescribing in those age…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50—59 Years by Schmader, Kenneth E., Levin, Myron J., Gnann, John W., McNeil, Shelly A., Vesikari, Timo, Betts, Robert F., Keay, Susan, Stek, Jon E., Bundick, Nickoya D., Su, Shu-Chih, Zhao, Yanli, Li, Xiaoming, Chan, Ivan S. F., Annunziato, Paula W., Parrino, Janie

    Published in Clinical infectious diseases (01-04-2012)
    “…Background. Herpes zoster (HZ) adversely affects individuals aged 50—59, but vaccine efficacy has not been assessed in this population. This study was designed…”
    Get full text
    Journal Article
  10. 10

    Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease by Corder, E. H, Saunders, A. M, Risch, N. J, Strittmatter, W. J, Schmechel, D. E, Gaskell, P. C, Rimmler, J. B, Locke, P. A, Conneally, P. M, Schmader, K. E, Small, G. W, Roses, A. D, Haines, J. L, Pericak-Vance, M. A

    Published in Nature genetics (01-06-1994)
    “…Gene dosage of the apolipoprotein E (APOE) epsilon 4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we…”
    Get full text
    Journal Article
  11. 11

    The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study by Drolet, Mélanie, Brisson, Marc, Schmader, Kenneth E, Levin, Myron J, Johnson, Robert, Oxman, Michael N, Patrick, David, Blanchette, Caty, Mansi, James A

    “…Vaccination against herpes zoster is being considered in many countries. We conducted a multicentre prospective study to describe the impact of herpes zoster…”
    Get full text
    Journal Article
  12. 12

    Adverse Drug Events In High Risk Older Outpatients by Hanlon, Joseph T., Schmader, Kenneth E., Koronkowski, Michael J., Weinberger, Morris, Landsman, Pamela B., Samsa, Gregory P., Lewis, Ingrid K.

    Published in Journal of the American Geriatrics Society (01-08-1997)
    “…OBJECTIVE: To describe the prevalence, types, and consequences of adverse drug events (ADEs) in older outpatients with polypharmacy. DESIGN: A cohort study…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Biological, clinical, and psychosocial correlates at the interface of cancer and aging research by Dale, William, Mohile, Supriya G, Eldadah, Basil A, Trimble, Edward L, Schilsky, Richard L, Cohen, Harvey J, Muss, Hyman B, Schmader, Kenneth E, Ferrell, Betty, Extermann, Martine, Nayfield, Susan G, Hurria, Arti

    “…In September 2010, the Cancer and Aging Research Group, in collaboration with the National Cancer Institute and the National Institute on Aging, conducted the…”
    Get full text
    Journal Article
  14. 14

    Herpes Zoster in the Elderly: Issues Related to Geriatrics by SCHMADER, K

    Published in Clinical infectious diseases (01-04-1999)
    “…This article reviews specific clinical and research issues of herpes zoster related to geriatric medicine. Salient epidemiological and clinical issues include…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy by Hanlon, J T, Weinberger, M, Samsa, G P, Schmader, K E, Uttech, K M, Lewis, I K, Cowper, P A, Landsman, P B, Cohen, H J, Feussner, J R

    Published in The American journal of medicine (01-04-1996)
    “…To evaluate the effect of sustained clinical pharmacist interventions involving elderly outpatients with polypharmacy and their primary physicians. Randomized,…”
    Get more information
    Journal Article
  16. 16

    Postherpetic neuralgia in immunocompetent elderly people by Schmader, Kenneth

    Published in Vaccine (01-11-1998)
    “…The most menacing complication of herpes zoster in immunocompetent elderly people is chronic pain or postherpetic neuralgia (PHN). The cardinal epidemiological…”
    Get full text
    Journal Article
  17. 17

    Incidence and Predictors of All and Preventable Adverse Drug Reactions in Frail Elderly Persons After Hospital Stay by Hanlon, Joseph T., Pieper, Carl F., Hajjar, Emily R., Sloane, Richard J., Lindblad, Catherine I., Ruby, Christine M., Schmader, Kenneth E.

    “…Background. Adverse drug reactions (ADR) negatively impact life quality and are sometimes fatal. This study examines the incidence and predictors of all and…”
    Get full text
    Journal Article
  18. 18

    Vaccination against Herpes Zoster and Postherpetic Neuralgia by Oxman, Michael N., Levin, Myron J.

    Published in The Journal of infectious diseases (01-03-2008)
    “…Background. Herpes zoster (HZ) and postherpetic neuralgia (PHN) cause significant morbidity in older adults. The incidence and severity of HZ and PHN increase…”
    Get full text
    Journal Article
  19. 19

    A method for assessing drug therapy appropriateness by Hanlon, J T, Schmader, K E, Samsa, G P, Weinberger, M, Uttech, K M, Lewis, I K, Cohen, H J, Feussner, J R

    Published in Journal of clinical epidemiology (01-10-1992)
    “…This study evaluated the reliability of a new medication appropriateness index. Using the index, independent assessments were made of chronic medications taken…”
    Get more information
    Journal Article
  20. 20

    The Prevalence and 3-Year Incidence of Dementia in Older Black and White Community Residents by Fillenbaum, Gerda G., Heyman, Albert, Huber, Marc S., Woodbury, Max A., Leiss, Jack, Schmader, Kenneth E., Bohannon, Arline, Trapp-Moen, Barbara

    Published in Journal of clinical epidemiology (01-07-1998)
    “…Objective: To determine the prevalence and 3-year incidence of dementia in Blacks and Whites age 65 and older in a five-county Piedmont area of North Carolina…”
    Get full text
    Journal Article